Cargando…

Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis

BACKGROUND: A relationship between non-neurological autoimmune (NNAI) disorders and psychosis has been widely reported but not yet subjected to meta-analysis. We conducted the first meta-analysis examining the association between NNAI disorders and psychosis and investigated the effect of 1) tempora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cullen, Alexis E., Holmes, Scarlett, Pollak, Thomas A., Blackman, Graham, Joyce, Dan W., Kempton, Matthew J., Murray, Robin M., McGuire, Philip, Mondelli, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269125/ https://www.ncbi.nlm.nih.gov/pubmed/30122288 http://dx.doi.org/10.1016/j.biopsych.2018.06.016

Ejemplares similares

Cortisol Responses to Naturally Occurring Psychosocial Stressors Across the Psychosis Spectrum: A Systematic Review and Meta-Analysis
por: Cullen, Alexis E., et al.
Publicado: (2020)

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
por: Kempton, Matthew J., et al.
Publicado: (2015)

Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis
por: Blackman, Graham, et al.
Publicado: (2023)

Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis
por: Reilly, Thomas J, et al.
Publicado: (2020)

S12. THE ‘AUTOANTIBODYOME’ IN PSYCHOSIS: A PILOT STUDY AND BLUEPRINT FOR BIOMARKER DISCOVERY
por: Pollak, Thomas, et al.
Publicado: (2018)

Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2022)

T15. LONGITUDINAL ASSOCIATIONS BETWEEN CHILDHOOD SALIVARY CORTISOL LEVELS AND PRODROMAL SYMPTOMS IN LATE ADOLESCENCE: FINDINGS FROM A HIGH-RISK COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
por: Hermans, Karlijn S. F. M., et al.
Publicado: (2021)

Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study
por: Reininghaus, Ulrich, et al.
Publicado: (2016)

Systematic review of the association between adverse life events and the onset and relapse of postpartum psychosis
por: Reilly, Thomas J., et al.
Publicado: (2023)

F220. THREAT ANTICIPATION AND NEGATIVE AFFECT IN EARLY PSYCHOSIS
por: Chavez-Baldini, UnYoung, et al.
Publicado: (2018)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

Neural correlates of emotional processing in psychosis risk and onset – A systematic review and meta-analysis of fMRI studies
por: Lukow, P.B., et al.
Publicado: (2021)

Neural and Behavioral Correlates of Aberrant Salience in Individuals at Risk for Psychosis
por: Roiser, Jonathan P., et al.
Publicado: (2013)

T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION
por: Davies, Cathy, et al.
Publicado: (2020)

M154. INTRA- AND INTER-SCANNER RELIABILITY OF GRAY MATTER VOLUME AND CORTICAL THICKNESS ESTIMATES: IMPLICATIONS FOR MULTICENTRE IMAGING STUDIES IN PSYCHOSIS
por: Hedges, Emily, et al.
Publicado: (2020)

2333. Influenza-Related Neurologic Complications in Hospitalized Children with Underlying Neurologic Disorders
por: Frankl, Sarah, et al.
Publicado: (2019)

Autoimmune Neurologic Disorders
por: Živković, Saša
Publicado: (2011)

Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study
por: Trotta, Antonella, et al.
Publicado: (2016)

White-matter hyperintensities in first-episode psychosis
por: Zanetti, Marcus V., et al.
Publicado: (2008)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Familial risk and childhood adversity interplay in the onset of psychosis
por: Trotta, Antonella, et al.
Publicado: (2015)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2014)

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
por: Appiah-Kusi, E., et al.
Publicado: (2020)

O1.2 PERIPHERAL INFLAMMATORY MARKERS ARE PREDICTIVE OF CLINICAL CHARACTERISTICS AND OUTCOME IN PSYCHOSIS
por: Blackman, Graham, et al.
Publicado: (2018)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022)

The Placebo Effect in Psychosis: Why It Matters and How to Measure It
por: Hird, Emily J., et al.
Publicado: (2023)

Glial cells and neurologic autoimmune disorders
por: Li, Zhao-Qing, et al.
Publicado: (2022)

Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape
por: Sami, Musa, et al.
Publicado: (2020)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis
por: Valli, I, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4odqnubns9mbl0jvja81vb29lh